THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro

Molecular Immunology

Volumn 88, Issue , 2017, Pages 58-68

  Shiratori, Hiromi ^a   Feinweber, Carmen ^a   Luckhardt, Sonja ^a   Linke, Bona ^b   Resch, Eduard ^a   Geisslinger, Gerd ^a,b   Weigert, Andreas ^b   Parnham, Michael J ^a  

^a FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Cell surface receptor; Gene expression; Human polarization marker; Macrophage; Phagocytosis

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CELL SURFACE MARKER; CELL SURFACE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; BIOLOGICAL MARKER; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; JURKAT CELL LINE; MACROPHAGE; MARKER GENE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PHASE CONTRAST MICROSCOPY; POLARIZATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SPINDLE CELL; STAPHYLOCOCCUS AUREUS; THP 1 MACROPHAGE; TRANSCRIPTION REGULATION; UPREGULATION; CELL LINE; CELL POLARITY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM;

BIOMARKERS; CELL DIFFERENTIATION; CELL LINE; CELL POLARITY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE PROTEINS; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS;

EID: 85020244740     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2017.05.027     Document Type: Article

References (89)

1. Allaire, M.A., et al. Prostaglandin E2 does not modulate CCR7 expression and functionality after differentiation of blood monocytes into macrophages. Int. J. Inflamm., 2013, 2013, 918016.
2. Ammon, C., et al. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology 100 (2000), 364–369.
3. Arnold, C.E., et al. A critical role for suppressor of cytokine signalling 3 in promoting M1 macrophage activation and function in vitro and in vivo. Immunology 141 (2014), 96–110.
4. Batista, C.F., et al. Evolution of phagocytic function in monocytes and neutrophils blood cells of healthy calves. J. Dairy Sci. 98 (2015), 8882–8888.
5. Berkhout, T.A., et al. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J. Biol. Chem. 272 (1997), 16404–16413.
6. Brown, G.D., Innate antifungal immunity: the key role of phagocytes. Annu. Rev. Immunol. 29 (2011), 1–21.
7. Bustin, S.A., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55 (2009), 611–622.
8. Chanput, W., et al. Characterization of polarized THP-1 macrophages and polarizing ability of LPS and food compounds. Food Funct. 4 (2013), 266–276.
9. Chanput, W., et al. THP-1 cell line: an in vitro cell model for immune modulation approach. Int. Immunopharmacol. 23 (2014), 37–45.
10. Chen, S., et al. Impact of detachment methods on M2 macrophage phenotype and function. J. Immunol. Methods 426 (2015), 56–61.
11. Chen, K., et al. Commensal bacteria-induced inflammasome activation in mouse and human macrophages is dependent on potassium efflux but does not require phagocytosis or bacterial viability. PLoS One, 11, 2016, e0160937.
12. Chen, J.Q., et al. Toll-like receptor pathways in autoimmune diseases. Clin. Rev. Allergy Immunol. 50 (2016), 1–17.
13. Crane, M.J., et al. The monocyte to macrophage transition in the murine sterile wound. PLoS One, 9, 2014, e86660.
14. Croker, B.A., et al. IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3. Immunol. Cell Biol. 90 (2012), 124–129.
15. Daigneault, M., et al. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One, 5, 2010, e8668.
16. De Santa, F., et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130 (2007), 1083–1094.
17. De Santa, F., et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 28 (2009), 3341–3352.
18. Devitt, A., et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392 (1998), 505–509.
19. El Chartouni, C., et al. Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiology 215 (2010), 821–825.
20. Eligini, S., et al. Human monocyte-derived macrophages spontaneously differentiated in vitro show distinct phenotypes. J. Cell. Physiol. 228 (2013), 1464–1472.
21. Etzerodt, A., Moestrup, S.K., CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid. Redox Signal. 18 (2013), 2352–2363.
22. Fabriek, B.O., et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 113 (2009), 887–892.
23. Fadok, V.A., et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 (1998), 890–898.
24. Fadok, V.A., et al. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108 (2001), 957–962.
25. Gasparini, C., et al. RelB/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophages. Cytokine 61 (2013), 736–740.
26. Gholijani, N., et al. Modulation of cytokine production and transcription factors activities in human Jurkat T cells by thymol and carvacrol. Adv. Pharm. Bull. 5 (2015), 653–660.
27. Gilroy, D., De Maeyer, R., New insights into the resolution of inflammation. Semin. Immunol. 27 (2015), 161–168.
28. Gorczynski, R.M., CD200:CD200R-mediated regulation of immunity. ISRN Immunol. 2012 (2012), 1–18.
29. Gordon, S., Martinez, F.O., Alternative activation of macrophages: mechanism and functions. Immunity 32 (2010), 593–604.
30. Gordon, S., The macrophage: past, present and future. Eur. J. Immunol. 37:Suppl. 1 (2007), S9–17.
31. Hamilton, J.A., Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8 (2008), 533–544.
32. Huynh, M.L., et al. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109 (2002), 41–50.
33. Jaguin, M., et al. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell. Immunol. 281 (2013), 51–61.
34. Kneidl, J., et al. Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides. Cell. Microbiol. 14 (2012), 914–936.
35. Krausgruber, T., et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12 (2011), 231–238.
36. Lang, R., et al. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169 (2002), 2253–2263.
37. Lawrence, T., Natoli, G., Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11 (2011), 750–761.
38. Madonna, S., et al. Suppressor of cytokine signaling 1 inhibits IFN-gamma inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation. FASEB J. 22 (2008), 3287–3297.
39. Mae, M., et al. The diacylated lipopeptide FSL-1 enhances phagocytosis of bacteria by macrophages through a Toll-like receptor 2-mediated signalling pathway. FEMS Immunol. Med. Microbiol. 49 (2007), 398–409.
40. Maess, M.B., et al. Selection of reliable reference genes during THP-1 monocyte differentiation into macrophages. BMC Mol. Biol., 11, 2010, 90.
41. Mancl, M.E., et al. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J. Biol. Chem. 280 (2005), 21078–21090.
42. Martinez, F.O., Gordon, S., The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep., 6, 2014, 13.
43. McNally, A.K., Anderson, J.M., Macrophage fusion and multinucleated giant cells of inflammation. Adv. Exp. Med. Biol. 713 (2011), 97–111.
44. Medeiros, A.I., et al. Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J. Exp. Med. 206 (2009), 61–68.
45. Mengubas, K., et al. Co-ordinated downregulation of bcl-2 and bax expression during granulocytic and macrophage-like differentiation of the HL60 promyelocytic leukaemia cell line. FEBS Lett. 394 (1996), 356–360.
46. Mia, S., et al. An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-beta yields a dominant immunosuppressive phenotype. Scand. J. Immunol. 79 (2014), 305–314.
47. Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8 (2008), 958–969.
48. Mosser, D.M., Zhang, X., Interleukin-10: new perspectives on an old cytokine. Immunol. Rev. 226 (2008), 205–218.
49. Motwani, M.P., Gilroy, D.W., Macrophage development and polarization in chronic inflammation. Semin. Immunol. 27 (2015), 257–266.
50. Mukhopadhyay, S., et al. Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia. Cell Host Microbe 8 (2010), 236–247.
51. Muraille, E., et al. TH1/TH2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism?. Front. Immunol., 5, 2014, 603.
52. Murray, P.J., Wynn, T.A., Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11 (2011), 723–737.
53. Murray, P.J., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41 (2014), 14–20.
54. Nakagawa, R., et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 17 (2002), 677–687.
55. Namgaladze, D., et al. AMP-activated protein kinase suppresses arachidonate 15-lipoxygenase expression in interleukin 4-polarized human macrophages. J. Biol. Chem. 290 (2015), 24484–24494.
56. Neele, A.E., et al. Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis. Eur. J. Pharmacol. 763 (2015), 79–89.
57. Negishi, H., et al. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 15989–15994.
58. Nolan, A., et al. Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS One, 4, 2009, e6600.
59. Orabona, C., et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5 (2004), 1134–1142.
60. Ouyang, X., et al. Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem. Biophys. Res. Commun. 354 (2007), 1045–1051.
61. Pedraza-Brindis, E.J., et al. Culture supernatants of cervical cancer cells induce an M2 phenotypic profile in THP-1 macrophages. Cell. Immunol. 301 (2016), 42–52, 10.1016/j.cellimm.2016.07.001.
62. Pena, O.M., et al. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J. Immunol. 186 (2011), 7243–7254.
63. Puhr, M., et al. SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling. Endocr. Relat. Cancer 17 (2010), 525–538.
64. Qin, Z., The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis 221 (2012), 2–11.
65. Satoh, T., et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11 (2010), 936–944.
66. Schlegel, R.A., et al. CD14 is a component of multiple recognition systems used by macrophages to phagocytose apoptotic lymphocytes. Cell Death Differ. 6 (1999), 583–592.
67. Schwende, H., et al. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukoc. Biol. 59 (1996), 555–561.
68. Sekhon-Loodu, S., et al. Docosahexaenoic acid ester of phloridzin inhibit lipopolysaccharide-induced inflammation in THP-1 differentiated macrophages. Int. Immunopharmacol. 25 (2015), 199–206.
69. Sharif, O., et al. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol., 8, 2007, 1.
70. Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122 (2012), 787–795.
71. Song, M.G., et al. NRF2 signaling negatively regulates phorbol-12-myristate-13-acetate (PMA)-induced differentiation of human monocytic U937 cells into pro-inflammatory macrophages. PLoS One, 10, 2015, e0134235.
72. Spano, A., et al. PMA withdrawal in PMA-treated monocytic THP-1 cells and subsequent retinoic acid stimulation, modulate induction of apoptosis and appearance of dendritic cells. Cell Prolif. 46 (2013), 328–347.
73. Spencer, M., et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am. J. Physiol. Endocrinol. Metab. 299 (2010), E1016–1027.
74. Spiller, K.L., et al. Differential gene expression in human, murine, and cell line-derived macrophages upon polarization. Exp. Cell Res. 347 (2016), 1–13.
75. Stankov, K., et al. Expression analysis of genes involved in apoptosis, proliferation and endoplasmic reticulum stress in ionomycin/PMA treated Jurkat cells. J. Balk. Union Oncol. 17 (2012), 369–376.
76. Strebovsky, J., et al. Suppressor of cytokine signaling proteins as regulators of innate immune signaling. Front. Biosci. Landmark 17 (2012), 1627–1639.
77. Tedesco, S., et al. Phenotypic activation and pharmacological outcomes of spontaneously differentiated human monocyte-derived macrophages. Immunobiology 220 (2015), 545–554.
78. Tschernig, T., et al. The importance of surfactant proteins-New aspects on macrophage phagocytosis. Ann. Anat. 208 (2016), 142–145, 10.1016/j.aanat.2016.07.005.
79. Vaddi, K., Newton, R.C., Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-beta family. J. Leukoc. Biol. 55 (1994), 756–762.
80. Vance, D.T., et al. A phagocytosis assay for oxidized low-density lipoprotein versus immunoglobulin G-coated microbeads in human U937 macrophages. Anal. Biochem. 500 (2016), 24–34.
81. Vogel, D.Y., et al. Human macrophage polarization in vitro: maturation and activation methods compared. Immunobiology 219 (2014), 695–703.
82. Wang, N., et al. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front. Immunol., 5, 2014, 614.
83. Wilson, H.M., SOCS proteins in macrophage polarization and function. Front. Immunol., 5, 2014, 357.
84. Xu, W., et al. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107 (2006), 4930–4937.
85. Xu, C., et al. Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes. Int. Immunopharmacol. 38 (2016), 223–232.
86. Xuan, W., et al. The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J. Leukoc. Biol. 97 (2015), 61–69.
87. Yoshimura, A., et al. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7 (2007), 454–465.
88. Zhou, D., et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell. Signal. 26 (2014), 192–197.
89. Zizzo, G., Cohen, P.L., The PPAR-gamma antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-gamma in human macrophage polarization. J. Inflamm., 12, 2015, 36.